PUBLISHER: The Business Research Company | PRODUCT CODE: 1939334
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939334
Bioabsorbable stents are vascular tubes used for unblocking blood vessels and subsequently dissolve within the body after a certain period.
The primary products in the bioabsorbable stents market consist of polymer-based and metal-based bioabsorbable stents. These stents, also referred to as bioresorbable stents or vascular scaffolds, are designed to fully disintegrate within the body. Additionally, these stents are categorized based on their absorption rates into slow-absorption and fast-absorption stents, and they find applications in treating coronary artery diseases and peripheral artery diseases.
Tariffs are influencing the bioabsorbable stents market by increasing costs of imported biodegradable polymers, specialty metals, precision manufacturing equipment, and coating technologies used in stent production. Cardiovascular device manufacturers in North America and Europe are most affected due to reliance on imported raw materials and fabrication tools, while Asia-Pacific faces cost pressures on export manufacturing. These tariffs are increasing development and production costs. However, they are also encouraging domestic material sourcing, localized stent manufacturing, and innovation in cost-effective bioabsorbable implant technologies.
The bioabsorbable stents market research report is one of a series of new reports from The Business Research Company that provides bioabsorbable stents market statistics, including bioabsorbable stents industry global market size, regional shares, competitors with a bioabsorbable stents market share, detailed bioabsorbable stents market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable stents industry. This bioabsorbable stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioabsorbable stents market size has grown rapidly in recent years. It will grow from $0.41 billion in 2025 to $0.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, adoption of interventional cardiology procedures, early use of biodegradable polymers in medical implants, growth of coronary stent procedures, advancements in vascular intervention techniques.
The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for temporary vascular support solutions, rising focus on long-term patient outcomes, expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, increasing regulatory approvals for novel stent materials. Major trends in the forecast period include increasing development of next-generation bioabsorbable materials, rising adoption of polymer-based bioabsorbable stents, growing focus on reduced long-term complications, expansion of clinical trials for peripheral applications, enhanced emphasis on biocompatibility and safety.
The rising incidence of heart failure is expected to drive growth in the bioabsorbable stents market in the coming years. Heart failure occurs when the heart muscle is unable to efficiently pump blood, leading to fluid buildup in the body. Bioabsorbable stents are used in managing heart failure to improve cardiac function and alleviate symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based source of information on stroke, heart disease, and treatments, reports that 750,000 individuals in Canada are currently diagnosed with heart failure, with an annual increase of 100,000 new cases. By 2030, healthcare expenditures related to heart failure in Canada are projected to reach $2.8 billion annually. Consequently, the growing prevalence of heart failure is expected to propel the bioabsorbable stents market.
The expanding geriatric population is also driving growth in the bioabsorbable stents market. The geriatric population includes adults aged 65 years and older, a group that is increasing due to longer life expectancy supported by advances in healthcare. Bioabsorbable stents offer significant benefits for older patients, as they gradually dissolve after restoring blood flow, reducing long-term complications and avoiding permanent implants in individuals at higher risk of late adverse events. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, the global population aged 80 and above is expected to triple by 2050, reaching approximately 426 million. Therefore, the growing geriatric population is a key factor driving the market for bioabsorbable stents.
Major companies operating in the bioabsorbable stents market are focusing on technological innovations, such as next-generation bioresorbable cardiac stents, to enhance their market presence and profitability. These advanced stents are designed for coronary artery disease treatment and are made from biodegradable materials that dissolve over time after keeping the artery open. For example, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, received market approval from China's National Medical Products Administration (NMPA) for Firesorb, the world's first next-generation fully bioresorbable cardiac stent. Firesorb is designed to completely dissolve within three years, substantially reducing long-term complications such as thrombosis. Clinical trials involving 1,468 patients demonstrated a low thrombosis rate of 0.32% and a four-year target lesion failure rate of just 4.3%. Medical experts have highlighted its innovative thin-strut design and superior endothelial coverage compared to previous stent generations.
Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.
North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioabsorbable stents market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The bioabsorbable stents market consists of sales of polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioabsorbable Stents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bioabsorbable stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioabsorbable stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioabsorbable stents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.